SCHEMBL29850985

SCHEMBL29850985

CCN1CCCC1(N)C(=O)O

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.31
INMT O95050 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1645706 0.81 BCHE (0.36)
SCHEMBL21382759 0.78 INMT (0.32) DPP4INMT
SCHEMBL7154976 0.74 FFAR3 (0.34) DPP4INMT
SCHEMBL8895901 0.74 INMT (0.31) INMT
SCHEMBL8896203 0.74 INMT (0.31) INMT
SCHEMBL3315633 0.74 FFAR3 (0.34) DPP4INMT
SCHEMBL28833355 0.74 FFAR3 (0.32)
SCHEMBL28833356 0.74 FFAR3 (0.32)
SCHEMBL9650008 0.73 HSD11B1 (0.31) INMT
SCHEMBL10728333 0.73 HSD11B1 (0.31) INMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4291188-A1 INHIBITORS OF CGAS ACTIVITY AS THERAPEUTIC AGENTS Bellbrook Labs, Llc (US) 2023-12-20 EP claimed
WO-2022174012-A1 INHIBITORS OF cGAS ACTIVITY AS THERAPEUTIC AGENTS BELLBROOK LABS, LLC (US) 2022-08-18 WO claimed